BCRX Financials
BioCryst Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$10.05
Market Cap
$1.83B
P/E Ratio
-23.4
EPS
$-0.05
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-88.88M
EPS (Diluted)
$-0.43
Balance Sheet Highlights
Total Assets
$490.42M
Total Liabilities
$966.35M
Shareholders Equity
-
Cash & Equivalents
$104.71M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-52.02M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
18.6%
Net Margin
-1.5%
ROE
-1925.4%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is BCRX revenue?
View BCRX's income statement for detailed revenue data.
Is BCRX profitable?
BCRX reported a loss of $88.88M in the most recent quarter. The net profit margin is -1.5%.
What is BCRX market cap?
BCRX has a market capitalization of $1.83B, making it a small-cap stock.
Does BCRX have debt?
View BCRX's balance sheet for debt information.
What is BCRX cash flow?
Cash flow data is available in the full financial statements.